Skip to site menu Skip to page content

Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG

By SCHOTT Pharma AG & Co. KgaA
A critical issue that may occur with IV drugs is microbial contamination. This contamination can cause severe bloodstream infections in patients, resulting in a high mortality rate of 15%-30% and producing substantial costs for the health care system [10]. Studies emphasise that critical infections also happen in countries with high nursing standards and found that 6% of disposable syringes were contaminated in the operating room and 16% in the general ward [11].
Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Related Content